MediPharm Labs Corp. (TSX: LABS)
Canada
· Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Dec 20, 2024, 2:27 PM EST
MediPharm Labs Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -11.76 | -13.08 | -29.98 | -54.8 | -66.35 | 1.65 | Upgrade
|
| Depreciation & Amortization | 2.76 | 2.52 | 2.87 | 5.63 | 10.81 | 2.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | 0.12 | 0.99 | -0.07 | 0.15 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.18 | - | 4.24 | 2.04 | - | Upgrade
|
| Stock-Based Compensation | 1.94 | 2.03 | 2.87 | 2.4 | 2.68 | 15.5 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | -1.92 | 0.13 | 6.8 | - | - | Upgrade
|
| Other Operating Activities | 0.81 | -5.63 | 0.8 | 16.23 | -4.28 | 5.38 | Upgrade
|
| Change in Accounts Receivable | 5 | 6.29 | 3.62 | 5.93 | -2.09 | -21.08 | Upgrade
|
| Change in Inventory | 0.35 | 3.11 | -0.1 | 2.49 | 29.41 | -42.08 | Upgrade
|
| Change in Accounts Payable | 0.57 | -5.17 | 1.49 | -8.11 | -4.57 | 11.24 | Upgrade
|
| Change in Income Taxes | - | 0.13 | -0.01 | 4.26 | -4.49 | - | Upgrade
|
| Change in Other Net Operating Assets | -1.98 | -0.92 | 1.24 | 1.79 | -1.08 | 1.68 | Upgrade
|
| Operating Cash Flow | -2.32 | -12.34 | -16.07 | -13.21 | -37.77 | -25.18 | Upgrade
|
| Capital Expenditures | -0.23 | -0.47 | -0.86 | -0.78 | -7.5 | -32.44 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.75 | 2.08 | 0.01 | 0.82 | 0.06 | - | Upgrade
|
| Cash Acquisitions | - | 1.01 | - | - | - | - | Upgrade
|
| Divestitures | 4.25 | 4.25 | 6.01 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | -0 | -0.11 | Upgrade
|
| Investing Cash Flow | 4.77 | 6.87 | 5.16 | 0.04 | -7.45 | -32.55 | Upgrade
|
| Short-Term Debt Issued | - | 1.07 | 1.34 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 36.14 | 9.7 | Upgrade
|
| Total Debt Issued | 0.8 | 1.07 | 1.34 | - | 36.14 | 9.7 | Upgrade
|
| Short-Term Debt Repaid | - | -1.76 | -0.82 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.25 | -0.13 | -2.96 | -14.06 | -6.2 | Upgrade
|
| Total Debt Repaid | -3.11 | -2.01 | -0.95 | -2.96 | -14.06 | -6.2 | Upgrade
|
| Net Debt Issued (Repaid) | -2.31 | -0.94 | 0.39 | -2.96 | 22.08 | 3.5 | Upgrade
|
| Issuance of Common Stock | - | - | - | 30.92 | 5.31 | 85.31 | Upgrade
|
| Other Financing Activities | 0.46 | 0.58 | 0.4 | -0.15 | -0.97 | -0.31 | Upgrade
|
| Financing Cash Flow | -1.84 | -0.37 | 0.8 | 27.8 | 26.42 | 88.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.46 | -0.33 | 0.15 | -0.43 | 0.08 | - | Upgrade
|
| Net Cash Flow | 0.14 | -6.16 | -9.97 | 14.2 | -18.71 | 30.78 | Upgrade
|
| Free Cash Flow | -2.55 | -12.81 | -16.93 | -14 | -45.28 | -57.61 | Upgrade
|
| Free Cash Flow Margin | -6.53% | -38.75% | -76.56% | -64.47% | -125.72% | -44.57% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.06 | -0.06 | -0.33 | -0.43 | Upgrade
|
| Cash Interest Paid | 0.36 | 0.26 | 0.03 | 0.01 | 0.64 | 0.8 | Upgrade
|
| Cash Income Tax Paid | - | -0.27 | -0.01 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 6.81 | -0.1 | -4.55 | -6.42 | -31.95 | -55.97 | Upgrade
|
| Unlevered Free Cash Flow | 7.22 | 0.13 | -4.53 | 0.15 | -27.03 | -55.7 | Upgrade
|
| Change in Net Working Capital | -6.36 | -3.84 | -7.95 | -21.47 | -10.37 | 46.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.